BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24026733)

  • 1. Tardive dyskinesia associated with anastrozole.
    Manjunatha N; Ganjekar S; Mahendra JV; Kilara N; Srinivasa R
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E27-8. PubMed ID: 24026733
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism.
    Yu R
    Endocrine; 2016 Sep; 53(3):868-9. PubMed ID: 27369187
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
    Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
    Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World's largest breast cancer treatment trial supports anastrozole use.
    Oncology (Williston Park); 2002 Jan; 16(1):63. PubMed ID: 11831610
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful desensitisation to Anastrozole.
    Rodrigues J; Malheiro D; Botelho C; Cruz MC; Castel-Branco MG
    Allergol Immunopathol (Madr); 2009; 37(1):50-1. PubMed ID: 19268063
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and tolerability of endocrine therapies used in the treatment of advanced breast cancer.
    Bland KI; Buzdar AU
    Ann Surg Oncol; 1999 Dec; 6(8 Suppl):12S-13S. PubMed ID: 10619454
    [No Abstract]   [Full Text] [Related]  

  • 7. Anastrozole: brain draining or sparing?
    Berga SL
    Lancet Oncol; 2008 Oct; 9(10):913-4. PubMed ID: 19071243
    [No Abstract]   [Full Text] [Related]  

  • 8. Anastrozole-related acute hepatitis with autoimmune features: a case report.
    Inno A; Basso M; Vecchio FM; Marsico VA; Cerchiaro E; D'Argento E; Bagalà C; Barone C
    BMC Gastroenterol; 2011 Mar; 11():32. PubMed ID: 21453541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors and arthralgia.
    Donnellan PP; Douglas SL; Cameron DA; Leonard RC
    J Clin Oncol; 2001 May; 19(10):2767. PubMed ID: 11352973
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy.
    Valakh V; Trombetta MG; Werts ED; Labban G; Khalid MK; Kaminsky A; Parda D
    Am J Clin Oncol; 2011 Jun; 34(3):245-8. PubMed ID: 20622644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anastrozole-induced subacute cutaneous lupus erythematosus.
    Trancart M; Cavailhes A; Balme B; Skowron F
    Br J Dermatol; 2008 Mar; 158(3):628-9. PubMed ID: 18070201
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.
    ; Buzdar A; Howell A; Cuzick J; Wale C; Distler W; Hoctin-Boes G; Houghton J; Locker GY; Nabholtz JM
    Lancet Oncol; 2006 Aug; 7(8):633-43. PubMed ID: 16887480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anastrozole can cause severe hypercalcaemia mimicking primary hyperparathyroidism.
    Järhult J
    Breast Cancer; 2014 May; 21(3):379-81. PubMed ID: 21290264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreo-retinal traction and anastrozole use.
    Eisner A; Thielman EJ; Falardeau J; Vetto JT
    Breast Cancer Res Treat; 2009 Sep; 117(1):9-16. PubMed ID: 18712596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does anastrozole affect bone resorption similarly in early and late postmenopausal women?
    Powell DE; Cochrane RA; Davie MW
    Calcif Tissue Int; 2011 Mar; 88(3):223-30. PubMed ID: 21170709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.
    Sestak I; Cuzick J; Sapunar F; Eastell R; Forbes JF; Bianco AR; Buzdar AU;
    Lancet Oncol; 2008 Sep; 9(9):866-72. PubMed ID: 18703382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer.
    Lavrenkov K; Man S; Geffen DB; Cohen Y
    Isr Med Assoc J; 2002 Mar; 4(3):176-7. PubMed ID: 11908256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No pain, no gain: a fallacy so far.
    Gradishar WJ
    J Clin Oncol; 2015 Jan; 33(3):235-7. PubMed ID: 25512459
    [No Abstract]   [Full Text] [Related]  

  • 20. Lichen sclerosus in breast cancer survivor.
    Vieira-Baptista P
    J Gen Intern Med; 2013 Mar; 28(3):344. PubMed ID: 23299266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.